Echo Street Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Echo Street Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-6,392	Closed	-$827K	–	221
2023 Q3	$827K	Buy	6,392 +2,062	+48%	+$275K	0.01%	171
2023 Q2	$537K	Buy	+4,330	New	+$583K	﹤0.01%	251
2022 Q4	–	Sell	-9,142	Closed	-$1.22M	–	578
2022 Q3	$1.22M	Buy	+9,142	New	+$1.39M	0.01%	141
2022 Q2	–	Sell	-1,326	Closed	-$206K	–	631
2022 Q1	$206K	Sell	1,326 -2,215	-63%	-$321K	﹤0.01%	558
2021 Q4	$451K	Buy	+3,541	New	+$465K	﹤0.01%	433
2021 Q2	–	Sell	-1,434	Closed	-$236K	–	660
2021 Q1	$236K	Buy	+1,434	New	+$236K	﹤0.01%	466

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Echo Street Capital Management's JAZZ Position: Q4 2023 in Review

Echo Street Capital Management sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2023, closing a stake of 6,392 shares — an estimated $827K sold.

Echo Street Capital Management first reported a position in JAZZ in Q1 2021 and held it in 6 quarters. The position peaked at $1.22M in Q3 2022. 500 funds tracked by Wall St. Rank hold JAZZ as of Q4 2023.

Echo Street Capital Management reported no remaining Jazz Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
Echo Street Capital Management sold 6,392 Jazz Pharmaceuticals shares in Q4 2023, an estimated $827K.
Echo Street Capital Management first reported a position in Jazz Pharmaceuticals in Q1 2021 and held it in 6 quarters.
Echo Street Capital Management's Jazz Pharmaceuticals position peaked at $1.22M in Q3 2022.
500 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2023.

Based on Echo Street Capital Management's 13F filing for Q4 2023, filed 8 Feb 2024.